These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27574588)

  • 1. Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients.
    Atta MM; Atta HM; Gad MA; Rashed LA; Said EM; Hassanien Sel-S; Kaseb AO
    J Hepatocell Carcinoma; 2016; 3():19-24. PubMed ID: 27574588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients.
    Alzamzamy A; Elsayed H; Abd Elraouf M; Eltoukhy H; Megahed T; Aboubakr A
    World J Gastrointest Oncol; 2021 Jun; 13(6):600-611. PubMed ID: 34163576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality.
    Youssef AA; Issa HA; Omar MZ; Behiry EG; Elfallah AA; Hasaneen A; Darwish M; Ibrahim DB
    Clin Exp Gastroenterol; 2018; 11():431-438. PubMed ID: 30538523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.
    Li X; Feng GS; Zheng CS; Zhuo CK; Liu X
    World J Gastroenterol; 2004 Oct; 10(19):2878-82. PubMed ID: 15334691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
    Nabih MI; Aref WM; Fathy MM
    Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma.
    An FQ; Matsuda M; Fujii H; Matsumoto Y
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):153-60. PubMed ID: 10741909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma.
    Yvamoto EY; Ferreira RF; Nogueira V; Pinhe MA; Tenani GD; Andrade JG; Baitello ME; Gregório ML; Fucuta PS; Silva RF; Souza DR; Silva RC
    Genet Mol Res; 2015 Dec; 14(4):17453-62. PubMed ID: 26782388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma.
    Jinno K; Tanimizu M; Hyodo I; Nishikawa Y; Hosokawa Y; Doi T; Endo H; Yamashita T; Okada Y
    J Gastroenterol; 1998 Jun; 33(3):376-82. PubMed ID: 9658317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma.
    Amr KS; Elmawgoud Atia HA; Elazeem Elbnhawy RA; Ezzat WM
    Genes Dis; 2017 Dec; 4(4):215-221. PubMed ID: 30258925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients.
    Demerdash HM; Hussien HM; Hassouna E; Arida EA
    Biomed Res Int; 2017; 2017():1806069. PubMed ID: 28642869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma.
    Talaat RM; Salem TA; El-Masry S; Imbarek A; Mokhles M; Abdel-Aziz A
    J Med Virol; 2014 Jul; 86(7):1120-9. PubMed ID: 24677137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma.
    Wang D; Luo L; Chen W; Chen LZ; Zeng WT; Li W; Huang XH
    Oncol Rep; 2014 Mar; 31(3):1199-204. PubMed ID: 24366206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.
    Adamek A; Kasprzak A; Mikoś H; Przybyszewska W; Seraszek-Jaros A; Czajka A; Sterzyńska K; Mozer-Lisewska I
    Oncol Rep; 2013 Sep; 30(3):1337-45. PubMed ID: 23784592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.